Harahap Wirsma Arif, Nindrea Ricvan Dana
Surgical Oncology Division, Faculty of Medicine, Universitas Andalas, Dr M Djamil, General Hospital Padang, West Sumatera Province, Indonesia.
Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta City, Indonesia.
Open Access Maced J Med Sci. 2019 Feb 27;7(4):690-695. doi: 10.3889/oamjms.2019.151. eCollection 2019 Feb 28.
Cause of recurrence of breast cancer is multifactorial. Also, the occurrence of breast cancer in Asian patients has some different factors from the recurrence of breast cancer in western countries.
This study aims to determine the prognostic factors of local-regional recurrence in patients with operable breast cancer in Asia.
The authors conducted a meta-analysis of published research articles published in an online database of PubMed, ProQuest and EBSCO between January 2000 and July 2018. Pooled risk ratios (RR) were calculated using fixed and random-effect models. Data were processed by using Review Manager 5.3 (RevMan 5.3).
This study reviewed 879 articles. There were 11 studies conducted a systematic review then continued by meta-analysis of relevant data with total patients involved were 5,213 patients. The prognostic factors found of local-regional recurrence in patients with operable breast cancer were Nodal (N) stage with the highest risk ratio (RR = 6.35 [95% CI 3.78-10.67]) followed by HER2 positive (RR = 2.14 [95% CI 1.16-3.97]), stage of cancer (RR = 1.82 [95% CI 1.44-2.31]), tumor size (RR = 1.55 [95% CI 1.04-2.31]), tumor grade (RR = 1.43 [95% CI 1.23-1.65]), PR status (RR = 0.65 [95% CI 0.48-0.88]) and the least was ER status (RR = 0.60 [95% CI 0.39-0.91]). Homogeneity of variance was found in N stage, tumor size and tumor grade for recurrence of operable breast cancer.
This meta-analysis confirmed the correlation of N stage, HER2, stage of cancer, tumour size, tumour grade, ER and PR status with recurrence in patients with operable breast cancer in Asia.
乳腺癌复发的原因是多因素的。此外,亚洲患者乳腺癌的发生有一些与西方国家乳腺癌复发不同的因素。
本研究旨在确定亚洲可手术乳腺癌患者局部区域复发的预后因素。
作者对2000年1月至2018年7月期间在PubMed、ProQuest和EBSCO在线数据库中发表的研究文章进行了荟萃分析。使用固定效应模型和随机效应模型计算合并风险比(RR)。数据使用Review Manager 5.3(RevMan 5.3)进行处理。
本研究共检索了879篇文章。有11项研究进行了系统评价,然后对相关数据进行荟萃分析,涉及的患者总数为5213例。可手术乳腺癌患者局部区域复发的预后因素中,淋巴结(N)分期的风险比最高(RR = 6.35 [95% CI 3.78 - 10.67]),其次是HER2阳性(RR = 2.14 [95% CI 1.16 - 3.97])、癌症分期(RR = 1.82 [95% CI 1.44 - 2.31])、肿瘤大小(RR = 1.55 [95% CI 1.04 - 2.31])、肿瘤分级(RR = 1.43 [95% CI 1.23 - 1.65])、PR状态(RR = 0.65 [95% CI 0.48 - 0.88]),最低的是ER状态(RR = 0.60 [95% CI 0.39 - 0.91])。在可手术乳腺癌复发的N分期、肿瘤大小和肿瘤分级中发现了方差齐性。
这项荟萃分析证实了N分期、HER2、癌症分期、肿瘤大小、肿瘤分级、ER和PR状态与亚洲可手术乳腺癌患者复发之间的相关性。